Walker Karen Marie bought KYTX
December 15, 2025 · Form 4 insider transaction
Walker Karen Marie bought 23,998 shares of Kyverna Therapeutics, Inc. at $4.83 per share, a transaction worth $115.9K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
23,998
Price
$4.83
Total value
$115.9K
InsiderWalker Karen Marie
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateDecember 15, 2025
Filing dateDecember 17, 2025
Shares owned after46,634
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The transactions reported in this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 12, 2025 in effect at the time of such transactions.